Published: 1 June 2017

Publications

Quarterly Summary of Medsafe’s Early Warning System Communications

This article is more than five years old. Some content may no longer be current.

Prescriber Update 38(2): 31
June 2017

The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices.

More information about the early warning system can be found on the Medsafe website (www.medsafe.govt.nz/Projects/B2/EWS.asp).

Consumer Information Leaflets provide information about medicines and medical devices or medical conditions to consumers.

Date	Communication	Topic
24 March 2017	Monitoring Communication	Animas Vibe Insulin Pump and Blood Glucose Analyser — ongoing issues with screen fade, cracked battery casing and other issues
24 March 2017	Alert Communication	Andrographis paniculata — potential risk for allergic reactions
20 March 2017	Media Release	Primodos
13 March 2017	Monitoring Communication	Viekira Pak and Viekira Pak-RBV — Possible effects on blood glucose control when used in patients with type 2 diabetes
2 March 2017	Monitoring Communication	Possible risk of hypothyroidism in infants exposed to iodine-containing contrast agents added to the medicines monitoring scheme
2 March 2017	Consumer Information Leaflet	Hydroxychloroquine — what you can expect when starting treatment
8 February 2017	Consumer Information Leaflet	Medicines for Gout

If you would like to receive Medsafe’s early warning communications you can subscribe at www.medsafe.govt.nz/profs/subscribe.asp.